Alesta Therapeutics

Acquired

Biotech

Founded 2021 · $75.8M raised

Employees
11–50
Founded
2021
Business Model
B2B
Total Funding
$75.8M
Last Round
$75.8M Series AJan 2025
Rounds
1
Acquisition Date
Aug 2026

About

Alesta Therapeutics is a biotech company developing novel oral small molecule therapies for underserved rare diseases. Its globally experienced team brings together diverse expertise to drive small molecule innovation, developing targeted and effective therapies for rare diseases where few options exist. With a patient-friendly approach, the company prioritizes safety, efficacy, and accessibility, and favors oral small molecules for delivery, scalability, and tissue penetration in chronic conditions.

Summary

Alesta Therapeutics is a Biotech company, founded in 2021. It has raised $75.8M in total across 1 round, most recently a $75.8M Series A round in Jan 2025.

Tech & App Stack

2 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

AcquisitionAug 2026

Sign up to see all 2 rounds

Series A through Acquisition — per-round amounts, valuations, and who invested in each round.

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Alesta Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/alesta-therapeutics"><img src="https://indexed.vc/api/badge/company/alesta-therapeutics" alt="Alesta Therapeutics on Indexed.vc" width="260" height="76" /></a>